Phase III Trial of Tamoxifen Alone vs. Tamoxifen Plus Radiation Therapy for Good Risk Duct Carcinoma In-Situ (DCIS) of the Female Breast
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Tamoxifen (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 19 Oct 2020 Biomarkers information updated
- 21 Apr 2008 The expected completion date for this trial is now 1 Feb 2004.
- 15 Aug 2006 Status change